EORTC Quality of Life Questionnaire - Prostate Cancer Module (EORTC QLQ-PR25)

EORTC Quality of Life Group


Basic description

  • Published in 2008

EORTC: European Organization for Research and Treatment of Cancer


EORTC Quality of Life Group

© Copyright 1999 EORTC Study Group on Quality of Life. All rights reserved
To be used in conjunction with the EORTC QLQ-C30 for assessing the quality of life of prostate cancer patients varying in disease stage and treatment modality (i.e. surgery, chemotherapy, radiotherapy, etc.)
Therapeutic area
  • Neoplasms
  • Male Urogenital Diseases
Therapeutic indication

Prostatic Neoplasms

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
60 translation(s)
Bibliographic reference(s) of the original questionnaire

van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008 Nov;44(16):2418-24 (PubMed abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us